SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-104866
Filing Date
2024-04-22
Accepted
2024-04-22 16:13:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d454010ddefa14a.htm DEFA14A 10961
2 GRAPHIC g454010g44k03.jpg GRAPHIC 361605
3 GRAPHIC g454010g44k04.jpg GRAPHIC 203385
  Complete submission text file 0001193125-24-104866.txt   787246
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36332 | Film No.: 24861346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)